Live Breaking News & Updates on Taysha Gene Therapies Inc

Stay updated with breaking news from Taysha gene therapies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Head-To-Head Analysis: Taysha Gene Therapies (NASDAQ:TSHA) vs. Bavarian Nordic A/S (OTCMKTS:BVNRY)

Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, valuation, profitability, risk and institutional ownership. Profitability This table compares Taysha […] ....

Hong Kong , University Of Texas Southwestern Medical Center , United States , Saudi Arabia , United Kingdom , Rabipur Rabavert , Taysha Gene Therapies Inc , National Cancer Institute , Public Health Service , Taysha Gene Therapies , Get Free Report , Bavarian Nordic , Gene Therapies , Taysha Gene , Given Taysha Gene Therapie , Texas Southwestern Medical , Public Health , Taysha Gene Therapies Daily ,

Taysha Gene Therapies (NASDAQ:TSHA) Stock Rating Reaffirmed by Canaccord Genuity Group

Canaccord Genuity Group reaffirmed their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report published on Thursday morning, Benzinga reports. Canaccord Genuity Group currently has a $7.00 price objective on the stock. TSHA has been the topic of a number of other research reports. Cantor Fitzgerald reissued an overweight […] ....

Victory Capital Management Inc , Canaccord Genuity Group , Capital Management , Taysha Gene Therapies Inc , Maven Securities , Capital Investment Advisors , Howard Capital Management Inc , Needham Company , Cantor Fitzgerald , Taysha Gene Therapies , Free Report , Genuity Group , Gene Therapies , Investment Advisors , Victory Capital Management , Get Free Report , Taysha Gene Therapies Daily , Nasdaq Tsha , Reiterated Rating , Canaccord Genuity Group Inc ,

Taysha Gene Therapies (NASDAQ:TSHA) PT Raised to $7.00 at Chardan Capital

Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price objective boosted by Chardan Capital from $5.00 to $7.00 in a research note published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other research firms have also weighed in on TSHA. JMP Securities reissued a market […] ....

United States , Exome Asset Management , Chicago Partners Investment Group , Vanguard Group Inc , Taysha Gene Therapies Inc , Goldman Sachs Group Inc , Virtu Financial , Cantor Fitzgerald , Needham Company , Taysha Gene Therapies , Free Report , Chardan Capital , Gene Therapies , Sachs Group , Partners Investment Group , Get Free Report , Taysha Gene Therapies Daily ,

Taysha Gene Therapies (NASDAQ:TSHA) PT Raised to $7.00 at Needham & Company LLC

Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price target boosted by Needham & Company LLC from $5.00 to $7.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. Separately, Cantor Fitzgerald reaffirmed an overweight rating and issued a $7.00 price target on […] ....

Acuta Capital Partners , Cantor Fitzgerald , Taysha Gene Therapies Inc , Needham Company , Vanguard Group Inc , Taysha Gene Therapies , Free Report , Gene Therapies , Capital Partners , Vanguard Group , Get Free Report , Taysha Gene Therapies Daily ,

Cantor Fitzgerald Reiterates "Overweight" Rating for Taysha Gene Therapies (NASDAQ:TSHA)

Cantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report released on Wednesday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price on the stock. Separately, Needham & Company LLC lifted their target price on shares of Taysha Gene Therapies from $5.00 to $7.00 […] ....

Citigroup Inc , Needham Company , Taysha Gene Therapies Inc , Acuta Capital Partners , Cantor Fitzgerald , Taysha Gene Therapies , Free Report , Gene Therapies , Capital Partners , Adage Capital Partners , Get Free Report , Taysha Gene Therapies Daily ,